logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
C

Christopher Cubitt

h. lee moffitt cancer center and research institute
H指数:29
被引数:2,193

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Longitudinal Associations Between Inflammatory Biomarkers and Fatigue in Patients With Colorectal Cancer: A Multicenter Study

结直肠癌患者中炎症生物标志物与疲劳的纵向关联：一项多中心研究

Cancer Medicine
IF3.1
2026-09-130
OAAI
Nicole C. Loroña; Louisa Liu; Elham Kazemian; Nicholas Acuna; Mary C. Playdon; Christopher L. Cubitt; Shaowli Kabir; Sylvia L. Crowder; Nathalie Nguyen; Maria Gomez; Victoria Damerell; Kathi Mooney; Patricia A. Erickson; Mmadili Ilozumba; Caroline Himbert; Erin Siegel; Cornelia M. Ulrich; Christopher I. Li; David Shibata; Adetunji T. Toriola; Jennifer Ose; Anita R. Peoples; Sheetal Hardikar; Doratha A. Byrd; Julienne E. Bower; Aasha I. Hoogland; Xiaoyin Li; Brent J. Small; Biljana Gigic; Heather S. L. Jim; Jane C. Figueiredo
Expanded antigen-specific donor regulatory T cells for GVHD prevention

扩增的抗原特异性供者调节性T细胞用于GVHD预防

Blood
IF23.1
2026-06-220
PRE
Joseph Pidala; Nicoletta Cieri; Michael J. Schell; Xiaofei Song; Yiren Shao; Biwei Cao; Dongliang Du; Ram Thapa; Brian Betts; William Janssen; Christopher Cubitt; Sean Yoder; Mandy O’Leary; Francisca Beato; Anandharaman Veerapathran; Meghan Menges; Michelle Burton; Nelli Bejanyan; Omar Castaneda-Puglianini; Hany Elmariah
Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial

帕博利珠单抗联合高剂量IL-2在晚期透明细胞肾细胞癌中的应用：一项2期试验的6年生存结局及分子特征

Nature Communications
IF15.7
2026-05-250
OAAI
Jeffrey S. Johnson; Justin W. Miller; Firas Hatoum; Michael J. Schell; Xiaoqing Yu; Gabriel Roman Souza; Sarah Mizelle; Keerthi Gullapalli; Adnan Fazili; Rohit Jain; Jonathan Chatzkel; Ling Cen; Jasreman Dhillon; Christopher Cubitt; Jiqiang Yao; Junmin Whiting; Jiannong Li; Jennifer Swank; Ghazal Jameel; Jingsong Zhang; Xuefeng Wang; Philippe E. Spiess; Mayer Fishman; Jad Chahoud
Neutralizing Antibody Response following a Third Dose of the mRNA-1273 Vaccine among Cancer Patients
VACCINES
IF3.4
2023-12-221
OAAI
Dukes, Christopher W.; Potez, Marine; Lancet, Jeffrey; Kuter, Barbara J.; Whiting, Junmin; Mo, Qianxing; Leav, Brett; Wang, Haixing; Vanas, Julie S.; Cubitt, Christopher L.; Isaacs-Soriano, Kimberly; Kennedy, Kayoko; Rathwell, Julie; Cobo, Julian Diaz; O'Nan, Wesley; Sirak, Bradley; Dong, Ning; Tan, Elaine; Hwu, Patrick; Giuliano, Anna R.; Pilon-Thomas, Shari
An Ex Vivo Platform for the Prediction of Clinical Response in Multiple Myeloma
CANCER RESEARCH
IF16.6
2017-06-1451
OAAI
Silva, Ariosto; Silva, Maria C.; Sudalagunta, Praneeth; Distler, Allison; Jacobson, Timothy; Collins, Aunshka; Tuan Nguyen; Song, Jinming; Chen, Dung-Tsa; Chen, Lu; Cubitt, Christopher; Baz, Rachid; Perez, Lia; Rebatchouk, Dmitri; Dalton, William; Greene, James; Gatenby, Robert; Gillies, Robert; Sontag, Eduardo; Meads, Mark B.; Shain, Kenneth H.

研究方向

暂未获取到该数据
D
Daniel M. Sullivan
H 指数:58论文数:406被引数:1.2万
J
Jana L. Dawson
H 指数:13论文数:69被引数:1,070
D
Damon R. Reed
H 指数:49论文数:333被引数:9,668
J
Joel G. Turner
H 指数:30论文数:125被引数:4,317
K
Kenneth H. Shain
H 指数:41论文数:474被引数:7,104
D
Diana Yu
H 指数:18论文数:43被引数:4,692
S
Saı̈d M. Sebti
H 指数:80论文数:485被引数:2.0万
L
Lori Hazlehurst
H 指数:39论文数:195被引数:5,885
C
Christopher W. Dukes
H 指数:4论文数:34被引数:53
M
Michael Kauffman
H 指数:55论文数:542被引数:1.3万